Dewan Zeng Ph.D., MBA, joined BeiGene in 2017 as Senior Director, Clinical Sciences, and transitioned to Business Development in January 2019. In her current role as Head of Search and Evaluation, she leads a team of professionals who identify and evaluate innovative products and technologies to complement BeiGene’s portfolio. Her team is also responsible for due diligence for in-licensing, out-licensing and clinical collaboration deals globally. Prior to joining BeiGene, Dewan worked at Pfizer, Gilead and CV Therapeutics, and held various leadership roles in clinical development and translational research. In her 23-year career in the pharmaceutical industry, she led multiple global development programs, from investigational new drug application to completion of Phase 1/Phase 2/Phase 3 clinical studies, and supported new drug application submissions and approvals of three pharmaceutical products in the U.S., Europe and China. Dewan received her B.S. in biochemistry from Peking University, her Ph.D. in biochemistry from the University of Virginia, and an MBA in global business strategy from Cal State University East Bay. She completed her postdoctoral training at the University of California San Francisco.